Topics
Podcast
Magazine
Popular Tags
More
Another possible disruptor of our circadian clock: aging eyes that admit less light.
Massachusetts General Hospital’s Merit Cudkowicz discovered a key to jumpstarting ALS research: pooling resources.
Out of favor for decades, testosterone replacement therapy is back–and so is the debate about a possible link to prostate cancer.
Almost eradicating the disease, as happened in the 1950s, led to a disastrous resurgence. Is now the time for a smarter, final push?
The bacteria inside us may form a symbiotic relationship that not only affects metabolism, but emotions and brain development as well.
Harvard psychology professor Matthew Nock has undertaken a large-scale study to understand why people take their own lives and find ways to assess those at risk.
The use of 3-D models to track a patient’s pain has roots in a sixteenth-century sketch by a German master.
Clock genes keep circadian rhythms in sync, coordinating cells’ essential work and possibly enhancing well-timed therapies.
Though critics call them overprescribed, ineffective and worse, the real story on antidepressants is more complicated.
Lacking a standardized test to assess a baby’s health at birth, anesthesiologist Virginia Apgar created a simple rubric that persists more than a half century later.
No Articles Found.
We use cookies and other tools to enhance your experience on our website and to analyze our web traffic. For more information about these cookies and the data collected, please refer to our Privacy Policy.